DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

513.88 -2.12 (-0.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $513.88 -0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $513.74
Previous Close $516.00
Daily Range $513.50 - $519.46
52-Week Range $269.50 - $519.46
Market Cap $53.1B
P/E Ratio 165.38
Dividend (Yield) $0.00 (0.0%)
Volume 771,387
Average Daily Volume 771,919
Current FY EPS $7.81

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Regeneron Earnings Shine, but All Eyes Are on the Pipeline

Regeneron topped estimates Thursday as Eylea sales continue to soar. But the stock failed to hold its gains, as all eyes appear to now be on the biotech's pipeline.

Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog

Sanofi And Regeneron's Other Potential Blockbuster

Regeneron-Sanofi's Sarilumab Meets Endpoints in Phase III - Analyst Blog

Stock Market News for May 21, 2015 - Market News

Health Care Sector Update for 05/21/2015: CALA, DRNA, REGN

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst B

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst Blog

Jim Cramer's 'Mad Money' Recap: Stick With the Peerless Winners

3 Drugs Stocks Nudging The Industry Higher

Regeneron/Sanofi Announce Positive Data on Dupilumab - Analyst Blog

Stock Market News for May 19, 2015 - Market News

See More REGN News...

REGN's Top Competitors

REGN $513.88 (-0.41%)
Current stock: REGN
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB